Cargando…
Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
There are still some unmet needs in the treatment of schizophrenia like the persistence of negative symptoms. Cariprazine is a new-generation antipsychotic with partial agonism of the dopamine receptors, distinct from other antipsychotics by its 10 times greater affinity for D3 receptors. This mecha...
Autores principales: | Montes, Jose M, Montes, Paloma, Hernández-Huerta, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868213/ https://www.ncbi.nlm.nih.gov/pubmed/33568908 http://dx.doi.org/10.2147/NDT.S298005 |
Ejemplares similares
-
Cariprazine in Three Special Different Areas: A Real-World Experience
por: Gesi, Camilla, et al.
Publicado: (2021) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel, Thomas
Publicado: (2021) -
Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series
por: Duque-Yemail, Juan D, et al.
Publicado: (2022) -
Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series
por: Bajouco, Miguel, et al.
Publicado: (2022) -
Cariprazine hydrochloride for schizophrenia
Publicado: (2021)